Also known as آسٹیوپوروسس مینجمنٹ
Family Physician
MBBS, MCPS (Family Medicine), MRCGP(INT)
Internal Medicine Specialist
MBBS, FCPS, M.C.P.S
Rheumatologist
MBBS, MCPS, MRCGP, DTTMH, MASTMH, MRACGP, Family Medicine Residency Training Certification
Rheumatologist
MBBS, MCPS, MRCGP, DTTMH, MASTMH, MRACGP, Family Medicine Residency Training Certification
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Internal Medicine)
Cardiologist
M.B.B.S, F.C.P.S
Internal Medicine Specialist
M.B.B.S., F.C.P.S., M.R.C.P. (UK)*
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Family Physician
M.B.B.S., Postgraduate Diploma in Endocrinology
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures